Residency · Aurora, CO
Sponsored by University of Colorado School of Medicine · Director Teri Schreiner
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial.
The Lancet. Neurology · 2021 · 399 citations · Meredith Schultz
International consensus on diagnosis and management of Dravet syndrome.
Epilepsia · 2022 · 196 citations · Kelly Knupp
Trofinetide for the treatment of Rett syndrome: a randomized phase 3 study.
Nature medicine · 2023 · 150 citations · Tim Benke
Safety and efficacy of ganaxolone in patients with CDKL5 deficiency disorder: results from the double-blind phase of a randomised, placebo-controlled, phase 3 trial.
The Lancet. Neurology · 2022 · 133 citations · Tim Benke, Scott Demarest
Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome: A Randomized Clinical Trial.
JAMA neurology · 2022 · 110 citations · Kelly Knupp
CDKL5 deficiency disorder: clinical features, diagnosis, and management.
The Lancet. Neurology · 2022 · 123 citations · Tim Benke, Scott Demarest
Acute flaccid myelitis: cause, diagnosis, and management.
Lancet (London, England) · 2021 · 133 citations · Teri Schreiner
Precision medicine for genetic epilepsy on the horizon: Recent advances, present challenges, and suggestions for continued progress.
Epilepsia · 2022 · 106 citations · Scott Demarest